全球对比剂短缺背景下常规胸部CT低对比剂用量方案的单一机构经验
本研究纳入361例在六台64-256排CT上接受低对比剂用量(LCV)胸部CT的患者,比较固定LCV与按体重LCV方案,并与263例既往标准对比剂用量(SCV)胸部CT对照。双能量模式主动脉强化显著高于单能量模式(250±99 HU vs 228±76 HU,P<0.001)。624次胸部CT中89.4%强化达最佳,LCVw亚最佳强化者多为超重/肥胖(30/48,62.5%,P<0.001)。
要点
- LCV胸部CT可在多厂商、多对比剂、多扫描仪、多方案条件下完成。
- 双能量模式主动脉强化250±99 HU,高于单能量模式的228±76 HU(P<0.001)。
- LCVw方案中体形较大者更易出现强化欠佳(30/48为超重/肥胖,P<0.001)。
核心结论
- LCV胸部CT可在复杂的多厂商、多对比剂、多扫描仪、多方案CT实践中施行,但体形较大的患者可能出现对比剂强化欠佳。
研究设计与样本
- 单机构经验研究,纳入361例(65±15岁;男:女173:188)在六台64-256排CT上接受LCV胸部CT的患者,采用单能量或双能量模式,按固定LCV方案(LCVf,n=103)或按体重LCV方案(LCVw,n=258)扫描,并与263例既往标准对比剂用量(SCV)胸部CT对照。
关键影像表现/征象
- 由两名胸部放射科医师独立评估胸部血管、心腔及胸膜-肺实质和纵隔异常的对比剂强化是否最佳。
- 记录主肺动脉干、升主动脉和降主动脉的CT衰减值。
- 将肺动脉强化分为最佳与亚最佳两组以评估观察者间一致性。
诊断标准与关键数值
- 双能量模式主动脉强化250±99 HU,高于单能量模式的228±76 HU(P<0.001)。
- 624次胸部CT中558次(89.4%)强化最佳。
- 亚最佳强化66/624次,其中LCVw组48/258次(18.6%)、LCVf组14/103次(13.6%)。
- LCVw组亚最佳强化者中30/48(62.5%)为超重/肥胖(P<0.001)。
临床应用与阅片要点
- LCV胸部CT可在多厂商、多对比剂、多扫描仪、多方案条件下施行。
- 体形较大的患者接受LCV胸部CT可能出现对比剂强化欠佳。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the effectiveness of low contrast volume (LCV) chest CT performed with multiple contrast agents on multivendor CT with varying scanning techniques.
METHODS: The study included 361 patients (65 ± 15 years; M: F 173:188) who underwent LCV chest CT on one of the six 64-256 detector-row CT scanners using single-energy (SECT) or dual-energy (DECT) modes. All patients were scanned with either a fixed-LCV (LCVf, n = 103) or weight-based LCV (LCVw, n = 258) protocol. Two thoracic radiologists independently assessed all LCV CT and patients' prior standard contrast volume (SCV, n = 263) chest CT for optimality of contrast enhancement in thoracic vasculature, cardiac chambers, and in pleuro-parenchymal and mediastinal abnormalities. CT attenuations were recorded in the main pulmonary trunk, ascending, and descending thoracic aorta. To assess the interobserver agreement, pulmonary arterial enhancement was divided into two groups: optimal or suboptimal.
RESULTS: There was no significant difference among patients' BMI (p = 0.883) in the three groups. DECT had a significantly higher aortic arterial enhancement (250 ± 99HU vs 228 ± 76 HU for SECT, p < 0.001). Optimal enhancement was present in 558 of 624 chest CT (89.4%), whereas 66 of 624 chest CT with suboptimal enhancement was noted in 48 of 258 LCVw (18.6%) and 14 of 103 LCVf (13.6%). Most patients with suboptimal enhancement with LCVw injection protocol were overweight/obese (30/48; 62.5%), (p < 0.001).
CONCLUSION: LCV chest CT can be performed across complex multivendor, multicontrast media, multiscanner, and multiprotocol CT practices. However, LCV chest CT examinations can result in suboptimal contrast enhancement in patients with larger body habitus.
引用
- Karout, Digumarthy, Savage, et al. Low Contrast Volume Protocol in Routine Chest CT Amid the Global Contrast Shortage: A Single Institution Experience. Acad Radiol. 2023. PMID: 37164818. doi:10.1016/j.acra.2023.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。